Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

PTC Therapeutics, Inc.

NASDAQ: PTCT · Life Sciences · 10 alerts · CIK 1070081

Share price
$60.97Close, Nov 16
Market cap
$5.09B
Shares outstanding
83.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All PTC Therapeutics, Inc. filings on SEC EDGAR ↗

4:32 PM ET 10-Q
Financial Results

PTC Therapeutics Q3 2026 Results: Net Loss of $51.7M

For the nine months ended September 30, 2026, PTC Therapeutics reported total revenues of $990.9 million and net income of $29.0 million, a significant decrease from the $817.6 million net income in the prior year period which was bolstered by high collaboration revenue. The company's balance sheet remains strong with $2.1 billion in cash, cash equivalents, and marketable securities, though it maintains a total stockholders' deficit of $191.2 million.

Key figure
Net loss $51.7M
4:11 PM ET 8-K
Financial Results

PTC Therapeutics Financial Results

PTC Therapeutics reported record third-quarter 2026 financial results, with total revenue reaching $358 million, driven by $182 million in sales from the Sephience launch. The company raised its full-year 2026 revenue guidance to a range of $1.29 billion to $1.32 billion and expects to complete its BLA submission for the ST-920 Fabry disease gene therapy in Q4 2026.

“We delivered another strong quarter of record product revenue led by the continued momentum of the Sephience launch, putting us firmly on track to achieve our cash flow breakeven milestone this year. Now at the one-year mark, the launch has been a success by all measures. With a strong patient base, the large global market, and the reports of meaningful treatment benefits, we look forward to continued growth both in the US and internationally.”

Matthew B. Klein, M.D., Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.